Prothena | PRTA - Należności Handlowe





Należności Handlowe Zmiana Data
Acadia Pharmaceuticals USD 148.38M 153K 2026-03
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Akebia Therapeutics USD 47.03M 19.19M 2025-12
ALKERMES USD 407.63M 73.6M 2026-03
Alnylam Pharmaceuticals USD 883.96M 106.39M 2026-03
Amgen USD 9.14B 432M 2026-03
Biogen USD 1.79B 76.6M 2026-03
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
Exelixis USD 328.95M 42.03M 2026-03
Immunic USD 333K 156K 2025-12
Incyte USD 1.05B 27.09M 2026-03
Ionis Pharmaceuticals USD 74M 8M 2026-03
MacroGenics USD 13.37M 55.86M 2025-12
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Neurocrine Biosciences USD 768.1M 81.3M 2026-03
Prothena USD 5.16M 0 2023-12
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
Vertex Pharmaceuticals USD 2B 56.7M 2026-03
Xoma USD 14.78M 4.96M 2024-06